Literature DB >> 17380431

Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection.

Paola Parrella1, Davide Seripa, Maria G Matera, Monica Rinaldi, Emanuela Signori, Carolina Gravina, Antonietta P Gallo, Maria Prencipe, Elvira Grandone, Luciano Mariani, Paola Cordiali, Aldo Di Carlo, Patrizia Stentella, Antonio Pachì, Vito M Fazio.   

Abstract

Genetic variants in the immunomodulatory gene mannose-binding lectin 2 (MBL2), were associated with risk, severity, and frequency of viral infections. In a case-control setting, we investigated the association of MBL2 functional polymorphisms with Human Papillomas Virus (HPV) infection. No differences between cases (HPV(+)) and controls (HPV(-)) were found in the distribution of each single genotypes or allele. Haplotype analysis did not show any difference between HPV+ and HPV(-) groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380431     DOI: 10.1007/s10654-007-9111-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  HPV and intraepithelial neoplasia recurrent lesions of the lower genital tract: assessment of the immune system.

Authors:  P Stentella; A Frega; M Ciccarone; L Cipriano; A Tinari; S Tzantzoglou; A Pachì
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

2.  Human mannose-binding protein functions as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; M R White; E M Anders; M Super; R A Ezekowitz; A I Tauber
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  A comparison of linkage disequilibrium measures for fine-scale mapping.

Authors:  B Devlin; N Risch
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

4.  Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.

Authors:  P Garred; H O Madsen; U Balslev; B Hofmann; C Pedersen; J Gerstoft; A Svejgaard
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

5.  Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.

Authors:  Chloe L Thio; Timothy Mosbruger; Jacquie Astemborski; Spencer Greer; Gregory D Kirk; Stephen J O'Brien; David L Thomas
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

Authors:  C B Woodman; S Collins; H Winter; A Bailey; J Ellis; P Prior; M Yates; T P Rollason; L S Young
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

Review 7.  Mannose-binding lectin: structure, function, genetics and disease associations.

Authors:  M W Turner; R M Hamvas
Journal:  Rev Immunogenet       Date:  2000

8.  Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection.

Authors:  K Sasaki; A Tsutsumi; N Wakamiya; K Ohtani; Y Suzuki; Y Watanabe; N Nakayama; T Koike
Journal:  Scand J Gastroenterol       Date:  2000-09       Impact factor: 2.423

9.  MBL genotype and risk of invasive pneumococcal disease: a case-control study.

Authors:  Suchismita Roy; Kyle Knox; Shelley Segal; David Griffiths; Catrin E Moore; Kenneth I Welsh; Alex Smarason; Nicholas P Day; William L McPheat; Derrick W Crook; Adrian V S Hill
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

10.  Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome.

Authors:  Peter Garred; Jens J Strøm; Lars Quist; Ellen Taaning; Hans O Madsen
Journal:  J Infect Dis       Date:  2003-10-15       Impact factor: 5.226

View more
  1 in total

1.  Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer.

Authors:  Carlos Afonso Maestri; Renato Nisihara; Guilherme P Ramos; Hellen Weinschutz Mendes; Iara Messias-Reason; Newton Sérgio de Carvalho
Journal:  Med Princ Pract       Date:  2017-11-07       Impact factor: 1.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.